Will Insurance Companies and Medicare reimburse for A2-73?
Having not spent a Billion Dollars to run trials like BP likes to do for expensive biologics. ( manufactured in lab donor animals and other expensive low volume manufacturing)
A2-73 as a chemical compound should be an easy to manufacture in large quantities for a relative low cost.
If it is of benefit it will be a low-cost drug therefore widely used. Cost should not be a limiting factor for widespread availability to most patients that would benefit.